Cargando…
Hepatitis C Virus Vaccine: Challenges and Prospects
The hepatitis C virus (HCV) causes both acute and chronic infection and continues to be a global problem despite advances in antiviral therapeutics. Current treatments fail to prevent reinfection and remain expensive, limiting their use to developed countries, and the asymptomatic nature of acute in...
Autores principales: | Duncan, Joshua D., Urbanowicz, Richard A., Tarr, Alexander W., Ball, Jonathan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157504/ https://www.ncbi.nlm.nih.gov/pubmed/32079254 http://dx.doi.org/10.3390/vaccines8010090 |
Ejemplares similares
-
The Role of Humoral Innate Immunity in Hepatitis C Virus Infection
por: Tarr, Alexander W., et al.
Publicado: (2012) -
Flexible and rapid construction of viral chimeras applied to hepatitis C virus
por: McClure, C. Patrick, et al.
Publicado: (2016) -
The past, present and future of neutralizing antibodies for hepatitis C virus
por: Ball, Jonathan K., et al.
Publicado: (2014) -
Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay
por: Urbanowicz, Richard A., et al.
Publicado: (2016) -
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance
por: Urbanowicz, Richard A., et al.
Publicado: (2016)